Anatomical and visual results of transconjunctival sutureles vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents

Amina I. Malik, Robert E. Foster, Zelia Correa, Michael R. Petersen, Daniel M. Miller, Christopher D. Riemann

Research output: Contribution to journalArticle

Abstract

PURPOSE: The purpose of this study was to report the observed outcomes of anticoagulated patients undergoing transconjunctival sutureless vitrectomies using subconjunctival anesthesia without preoperative cessation of anticoagulation and antiplatelet (AC/AP) agents. METHODS: A retrospective chart review was performed on patients taking AC/AP agents who were undergoing transconjunctival sutureless vitrectomies with subconjunctival anesthesia between January 2007 and June 2009. Intra-and postoperative complications (such as massive hemorrhage), anatomical results, satisfactory analgesia (informed by patients and recorded by surgeon), anatomical results, and visual acuity were documented. RESULTS: Sixty-three surgeries were performed on 56 eyes of 52 patients. Thirty-two patients were taking aspirin and clopidogrel, 18 were taking warfarin, 5 were taking clopidogrel, 3 were taking aspirin and warfarin, 2 were taking acetylsalicylic acid and dipyridamole, and 1 was taking warfarin and clopidogrel. All patients had satisfactory analgesia. No intraoperative complications occurred. Seven eyes (13%) had postoperative vitreous hemorrhage. Overall, 79% of patients had improved postoperative visual acuity, 16% of patients had unchanged visual acuity, and 5% of patients had worse visual acuity at last follow-up visit. CONCLUSION: Medical disease requiring systemic AC/AP therapy is often present in patients with vitreoretinal disease. Transconjunctival sutureless vitrectomies using subconjunctival anesthesia may be a safe and effective surgical option in select patients in whom cessation of AC/AP and/or delayed ophthalmic intervention is imprudent.

Original languageEnglish (US)
Pages (from-to)905-911
Number of pages7
JournalRetina
Volume32
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

Platelet Aggregation Inhibitors
Vitrectomy
Anticoagulants
Anesthesia
clopidogrel
Visual Acuity
Warfarin
Aspirin
Analgesia
Vitreous Hemorrhage
Postoperative Hemorrhage
Dipyridamole
Intraoperative Complications
Hemorrhage

Keywords

  • anticoagulation
  • antiplatelet
  • hemorrhage
  • subconjunctival anesthesia
  • sutureless transconjunctival vitrectomy
  • vitrectomy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Anatomical and visual results of transconjunctival sutureles vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents. / Malik, Amina I.; Foster, Robert E.; Correa, Zelia; Petersen, Michael R.; Miller, Daniel M.; Riemann, Christopher D.

In: Retina, Vol. 32, No. 5, 01.05.2012, p. 905-911.

Research output: Contribution to journalArticle

Malik, Amina I. ; Foster, Robert E. ; Correa, Zelia ; Petersen, Michael R. ; Miller, Daniel M. ; Riemann, Christopher D. / Anatomical and visual results of transconjunctival sutureles vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents. In: Retina. 2012 ; Vol. 32, No. 5. pp. 905-911.
@article{eddcdc41072244288fb7980e32c491cb,
title = "Anatomical and visual results of transconjunctival sutureles vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents",
abstract = "PURPOSE: The purpose of this study was to report the observed outcomes of anticoagulated patients undergoing transconjunctival sutureless vitrectomies using subconjunctival anesthesia without preoperative cessation of anticoagulation and antiplatelet (AC/AP) agents. METHODS: A retrospective chart review was performed on patients taking AC/AP agents who were undergoing transconjunctival sutureless vitrectomies with subconjunctival anesthesia between January 2007 and June 2009. Intra-and postoperative complications (such as massive hemorrhage), anatomical results, satisfactory analgesia (informed by patients and recorded by surgeon), anatomical results, and visual acuity were documented. RESULTS: Sixty-three surgeries were performed on 56 eyes of 52 patients. Thirty-two patients were taking aspirin and clopidogrel, 18 were taking warfarin, 5 were taking clopidogrel, 3 were taking aspirin and warfarin, 2 were taking acetylsalicylic acid and dipyridamole, and 1 was taking warfarin and clopidogrel. All patients had satisfactory analgesia. No intraoperative complications occurred. Seven eyes (13{\%}) had postoperative vitreous hemorrhage. Overall, 79{\%} of patients had improved postoperative visual acuity, 16{\%} of patients had unchanged visual acuity, and 5{\%} of patients had worse visual acuity at last follow-up visit. CONCLUSION: Medical disease requiring systemic AC/AP therapy is often present in patients with vitreoretinal disease. Transconjunctival sutureless vitrectomies using subconjunctival anesthesia may be a safe and effective surgical option in select patients in whom cessation of AC/AP and/or delayed ophthalmic intervention is imprudent.",
keywords = "anticoagulation, antiplatelet, hemorrhage, subconjunctival anesthesia, sutureless transconjunctival vitrectomy, vitrectomy",
author = "Malik, {Amina I.} and Foster, {Robert E.} and Zelia Correa and Petersen, {Michael R.} and Miller, {Daniel M.} and Riemann, {Christopher D.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1097/IAE.0b013e31822f55c4",
language = "English (US)",
volume = "32",
pages = "905--911",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Anatomical and visual results of transconjunctival sutureles vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents

AU - Malik, Amina I.

AU - Foster, Robert E.

AU - Correa, Zelia

AU - Petersen, Michael R.

AU - Miller, Daniel M.

AU - Riemann, Christopher D.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - PURPOSE: The purpose of this study was to report the observed outcomes of anticoagulated patients undergoing transconjunctival sutureless vitrectomies using subconjunctival anesthesia without preoperative cessation of anticoagulation and antiplatelet (AC/AP) agents. METHODS: A retrospective chart review was performed on patients taking AC/AP agents who were undergoing transconjunctival sutureless vitrectomies with subconjunctival anesthesia between January 2007 and June 2009. Intra-and postoperative complications (such as massive hemorrhage), anatomical results, satisfactory analgesia (informed by patients and recorded by surgeon), anatomical results, and visual acuity were documented. RESULTS: Sixty-three surgeries were performed on 56 eyes of 52 patients. Thirty-two patients were taking aspirin and clopidogrel, 18 were taking warfarin, 5 were taking clopidogrel, 3 were taking aspirin and warfarin, 2 were taking acetylsalicylic acid and dipyridamole, and 1 was taking warfarin and clopidogrel. All patients had satisfactory analgesia. No intraoperative complications occurred. Seven eyes (13%) had postoperative vitreous hemorrhage. Overall, 79% of patients had improved postoperative visual acuity, 16% of patients had unchanged visual acuity, and 5% of patients had worse visual acuity at last follow-up visit. CONCLUSION: Medical disease requiring systemic AC/AP therapy is often present in patients with vitreoretinal disease. Transconjunctival sutureless vitrectomies using subconjunctival anesthesia may be a safe and effective surgical option in select patients in whom cessation of AC/AP and/or delayed ophthalmic intervention is imprudent.

AB - PURPOSE: The purpose of this study was to report the observed outcomes of anticoagulated patients undergoing transconjunctival sutureless vitrectomies using subconjunctival anesthesia without preoperative cessation of anticoagulation and antiplatelet (AC/AP) agents. METHODS: A retrospective chart review was performed on patients taking AC/AP agents who were undergoing transconjunctival sutureless vitrectomies with subconjunctival anesthesia between January 2007 and June 2009. Intra-and postoperative complications (such as massive hemorrhage), anatomical results, satisfactory analgesia (informed by patients and recorded by surgeon), anatomical results, and visual acuity were documented. RESULTS: Sixty-three surgeries were performed on 56 eyes of 52 patients. Thirty-two patients were taking aspirin and clopidogrel, 18 were taking warfarin, 5 were taking clopidogrel, 3 were taking aspirin and warfarin, 2 were taking acetylsalicylic acid and dipyridamole, and 1 was taking warfarin and clopidogrel. All patients had satisfactory analgesia. No intraoperative complications occurred. Seven eyes (13%) had postoperative vitreous hemorrhage. Overall, 79% of patients had improved postoperative visual acuity, 16% of patients had unchanged visual acuity, and 5% of patients had worse visual acuity at last follow-up visit. CONCLUSION: Medical disease requiring systemic AC/AP therapy is often present in patients with vitreoretinal disease. Transconjunctival sutureless vitrectomies using subconjunctival anesthesia may be a safe and effective surgical option in select patients in whom cessation of AC/AP and/or delayed ophthalmic intervention is imprudent.

KW - anticoagulation

KW - antiplatelet

KW - hemorrhage

KW - subconjunctival anesthesia

KW - sutureless transconjunctival vitrectomy

KW - vitrectomy

UR - http://www.scopus.com/inward/record.url?scp=84862785223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862785223&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e31822f55c4

DO - 10.1097/IAE.0b013e31822f55c4

M3 - Article

C2 - 22298013

AN - SCOPUS:84862785223

VL - 32

SP - 905

EP - 911

JO - Retina

JF - Retina

SN - 0275-004X

IS - 5

ER -